Side-by-side comparison of AI visibility scores, market position, and capabilities
Kenvue (KVUE)-owned dermatologist-developed men's skincare and grooming line under Neutrogena brand; competing with Jack Black and L'Oréal Men Expert for the growing male skincare category.
Neutrogena MEN is a dermatologist-developed men's grooming and skincare line under the Neutrogena brand — offering cleansers, moisturizers, shaving solutions, anti-aging treatments, and body care products specifically formulated for men's skin characteristics (thicker epidermis, higher sebum production, shaving-related irritation) under a brand associated with clinical efficacy and dermatologist trust. Neutrogena is owned by Kenvue (NYSE: KVUE), the consumer health spinoff from Johnson & Johnson that completed its IPO in May 2023.
Beaverton global athletic footwear and apparel (NYSE: NKE) at $51.4B FY2024 revenue with 18% market share;
Nike, Inc. is a Beaverton, Oregon-based global athletic footwear, apparel, and equipment company — publicly traded on the New York Stock Exchange (NYSE: NKE) as a Dow Jones Industrial Average and S&P 500 component — generating $51.4 billion in fiscal year 2024 (ended May 31, 2024) revenue with approximately 83,700 employees worldwide and approximately 18% global athletic footwear market share. Nike brands include Nike (performance footwear, apparel, and equipment), Jordan Brand (lifestyle basketball and athletic), and Converse (lifestyle footwear). In September 2024, Elliott Hill returned to Nike as President and CEO (replacing John Donahoe who had led the company since 2020), launching a "Win Now" strategy focused on sport performance product investment, wholesale partner relationship restoration, and competitive positioning in running and basketball categories. Nike Direct (direct-to-consumer e-commerce and owned stores) generated 44% of FY2024 revenue. Nike was founded in 1964 as Blue Ribbon Sports by Phil Knight and Bill Bowerman; renamed Nike in 1978 with IPO in 1980.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.